Liberate Medical Funding Round

7/5/2023

Venture Equity

$6,200,000

Series B

The company intends to use the funds to support the pivotal clinical trial of the VentFree Respiratory Muscle Stimulator. The Series B funding will provide the resources to complete the PREVENT trial, in anticipation of FDA regulatory clearance and full commercial launch of VentFree.

Private & Independent

Medical Devices & Instruments

6400 Westwind Way A
Crestwood, KY 40014
USA

Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders. Liberate's lead product, the VentFree� respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support. VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation.